STAT inhibitors are drugs which target signal transducer and activator of transcription (STAT) proteins, a family of cytoplasmic induction factors. Inhibitors of STAT proteins are being developed for use in cancer therapy.[1]
This pharmacology-related article is a stub. You can help Wikipedia by expanding it.